Our mission at Semorex is to develop and commercialize innovative technolgies based on our proprietary imprinted polymers for
- Detection of toxic proteins (i.e., Ricin).
- Development of novel therapeutics for treatment of major diseases by selective removal of proteins from the GI tract (i.e., Gliadin - for Celiac disease, TNFa - for inflammatorry bowel diseases, Ghrelin - for obesity treatmement).
We have also developed
- Novel, non-toxic small-molecule therapeutics for cancer.
- Novel diagnosis of systemic fungal infection (lateral flow device, mass spetroscopy).